Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-24-007194
Filing Date
2024-10-17
Accepted
2024-10-17 15:17:02
Documents
82
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 TO FORM 10-Q cardiff_10qa1-063024.htm   iXBRL 10-Q/A 1451338
2 CERTIFICATION cardiff_ex3101.htm EX-31.1 12589
3 CERTIFICATION cardiff_ex3102.htm EX-31.2 12690
4 CERTIFICATION cardiff_ex3201.htm EX-32.1 4484
5 CERTIFICATION cardiff_ex3202.htm EX-32.2 4490
  Complete submission text file 0001683168-24-007194.txt   8338717

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdif-20240630.xsd EX-101.SCH 63541
7 XBRL CALCULATION FILE cdif-20240630_cal.xml EX-101.CAL 68243
8 XBRL DEFINITION FILE cdif-20240630_def.xml EX-101.DEF 238433
9 XBRL LABEL FILE cdif-20240630_lab.xml EX-101.LAB 426211
10 XBRL PRESENTATION FILE cdif-20240630_pre.xml EX-101.PRE 375101
85 EXTRACTED XBRL INSTANCE DOCUMENT cardiff_10qa1-063024_htm.xml XML 1510750
Mailing Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169
Business Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169 844-628-2100
Cardiff Lexington Corp (Filer) CIK: 0000811222 (see all company filings)

EIN.: 841044583 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-49709 | Film No.: 241377419
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 03 Life Sciences)